Medartis Holding AG

SWX:MED Rapporto sulle azioni

Cap. di mercato: CHF 793.1m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Medartis Holding Gestione

Gestione criteri di controllo 3/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Christoph Bronnimann

Amministratore delegato

CHF 1.9m

Compenso totale

Percentuale dello stipendio del CEO26.8%
Mandato del CEO5yrs
Proprietà del CEO0.3%
Durata media del management3.7yrs
Durata media del Consiglio di amministrazione3.4yrs

Aggiornamenti recenti sulla gestione

Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Apr 11
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Recent updates

The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business

Aug 27
The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business

Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares

Aug 21
Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares

When Should You Buy Medartis Holding AG (VTX:MED)?

May 10
When Should You Buy Medartis Holding AG (VTX:MED)?

Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Apr 11
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence

Feb 14
The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence

Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Oct 24
Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Is Medartis Holding (VTX:MED) A Risky Investment?

Oct 03
Is Medartis Holding (VTX:MED) A Risky Investment?

Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 06
Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)

Jun 21
Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)

Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital

Jan 31
Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital

Why Medartis Holding AG (VTX:MED) Could Be Worth Watching

Oct 30
Why Medartis Holding AG (VTX:MED) Could Be Worth Watching

These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat

Sep 07
These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat

When Should You Buy Medartis Holding AG (VTX:MED)?

Jul 29
When Should You Buy Medartis Holding AG (VTX:MED)?

Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

May 06
Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?

Feb 08
At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?

Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Jan 18
Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt

Nov 10
We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt

Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

Sep 29
Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital

Jun 08
Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital

How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?

Mar 16
How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?

We're Watching These Trends At Medartis Holding (VTX:MED)

Feb 09
We're Watching These Trends At Medartis Holding (VTX:MED)

Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain

Jan 04
Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain

What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?

Nov 19
What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Christoph Bronnimann rispetto agli utili di Medartis Holding?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

CHF 4m

Mar 31 2024n/an/a

CHF 2m

Dec 31 2023CHF 2mCHF 500k

CHF 619k

Sep 30 2023n/an/a

-CHF 3m

Jun 30 2023n/an/a

-CHF 7m

Mar 31 2023n/an/a

-CHF 6m

Dec 31 2022CHF 2mCHF 500k

-CHF 6m

Sep 30 2022n/an/a

-CHF 3m

Jun 30 2022n/an/a

-CHF 241k

Mar 31 2022n/an/a

CHF 3m

Dec 31 2021CHF 3mCHF 500k

CHF 7m

Sep 30 2021n/an/a

CHF 9m

Jun 30 2021n/an/a

CHF 12m

Mar 31 2021n/an/a

CHF 6m

Dec 31 2020CHF 2mCHF 467k

-CHF 944k

Sep 30 2020n/an/a

-CHF 3m

Jun 30 2020n/an/a

-CHF 4m

Mar 31 2020n/an/a

-CHF 1m

Dec 31 2019CHF 782kCHF 168k

CHF 2m

Compensazione vs Mercato: La retribuzione totale di Christoph ($USD 2.16M ) è superiore alla media delle aziende di dimensioni simili nel mercato Swiss ($USD 1.50M ).

Compensazione vs guadagni: La retribuzione di Christoph è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Christoph Bronnimann (58 yo)

5yrs

Mandato

CHF 1,866,937

Compensazione

Dr. Christoph Bronnimann is Chief Executive Officer at Medartis AG since September 2019. He has been the Chief Executive Officer and Member of Executive Management Board at Medartis Holding AG since Septem...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Christoph Bronnimann
CEO & Member of Executive Management Board5yrsCHF 1.87m0.27%
CHF 2.1m
Thomas Straumann
Founder & Vice Chairman26.7yrsCHF 291.97k41.41%
CHF 328.5m
Dirk Kirsten
CFO & Member of the Executive Management Board3.5yrsNessun dato0.029%
CHF 231.9k
Mareike Loch
VP of EMEA & Member of Executive Management Board4.1yrsNessun dato0.053%
CHF 424.2k
Manuel Schaer
CTO & Member of the Executive Board3.8yrsNessun dato0.017%
CHF 134.8k
Mario Casa
COO & Member of Management Board2.7yrsNessun dato0.0027%
CHF 21.3k
Inge Maes
Chief Human Resources Officer & Executive Management Board Memberno dataNessun datoNessun dato
Anisha Wharton
Head of Regulatory Affairs3.5yrsNessun datoNessun dato

3.7yrs

Durata media

55yo

Età media

Gestione esperta: Il team dirigenziale di MED è considerato esperto (durata media dell'incarico 3.6 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Thomas Straumann
Founder & Vice Chairman26.7yrsCHF 291.97k41.41%
CHF 328.5m
Damien Tappy
Independent Non-Executive Director6.7yrsCHF 188.29k0.19%
CHF 1.5m
Marco Gadola
Independent Chairman4.4yrsCHF 568.06k0.065%
CHF 516.3k
Ciro Roemer
Independent Director2.4yrsCHF 112.76k0.0096%
CHF 76.5k
Willi Miesch
Independent Non Executive Director14.7yrsCHF 161.68k4.55%
CHF 36.1m
Martha Shadan
Independent Non-Executive Directorless than a yearNessun datoNessun dato
Jennifer Dean
Independent Non-Executive Directorless than a yearNessun datoNessun dato
Nadia Schmidt
Independent Director2.4yrsCHF 171.53k0.0072%
CHF 57.3k

3.4yrs

Durata media

60.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di MED sono considerati esperti (durata media dell'incarico 3.3 anni).